Haas Jason
SEC insider (Form 3/4/5 filer). CIK 0001883821. Director at LIGAND PHARMACEUTICALS INC (LGND) and 2 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in JUPITER, FL.
Companies Haas Jason has filed insider reports for
- LIGAND PHARMACEUTICALS INC (LGND): Director
- Odyssey Therapeutics, Inc. (ODTX): Officer, Chief Financial Officer
- Syros Pharmaceuticals, Inc. (SYRS): Officer, Chief Financial Officer
Haas Jason
CIK: 0001883821
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect7.1K shares at avg. $292.81$2.1M - Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect6.1K shares at avg. $51.56$316K - Jun 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect3K shares at avg. $51.56$155K - Jun 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect1K shares at avg. $51.56$52K - Jun 12, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect3K shares at avg. $255.01$765K - Jun 12, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect3.5K shares at avg. $256.08$886K - Jun 5, 2026LGND
LIGAND PHARMACEUTICALS INC
AwardDirect836 shares- - May 8, 2026ODTX
Odyssey Therapeutics, Inc.
PurchaseDirect1K shares at avg. $20.00$20K - Jun 6, 2025LGND
LIGAND PHARMACEUTICALS INC
AwardDirect1.2K shares- - Nov 18, 2024SYRS
Syros Pharmaceuticals, Inc.
SaleDirect137.8K shares at avg. $0.21$29K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 |  LGND LIGAND PHARMACEUTICALS INC | Sale | 7,138 | $292.81 | $2,090,062 | Direct |
| Aug 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 6,138 | $51.56 | $316,475 | Direct |
| Jun 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 3,000 | $51.56 | $154,680 | Direct |
| Jun 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 1,000 | $51.56 | $51,560 | Direct |
| Jun 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 3,000 | $255.01 | $765,034 | Direct |
| Jun 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 3,461 | $256.08 | $886,286 | Direct |
| Jun 5, 2026 | LGND LIGAND PHARMACEUTICALS INC | Award | 836 | - | $0 | Direct |
| May 8, 2026 |  ODTX Odyssey Therapeutics, Inc. | Purchase | 1,000 | $20.00 | $20,000 | Direct |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | Award | 1,209 | - | - | Direct |
| Nov 18, 2024 |  SYRS Syros Pharmaceuticals, Inc. | Sale | 137,803 | $0.21 | $28,980 | Direct |
1-10 of 15 transactions